Cryo-Cell International Inc.

CCEL Healthcare Medical Care Facilities

Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024.

Revenue
−0.02%
EPS
+77.8%
Free cash flow
−58.4%
Total debt
−29.5%

Quarter to August 2026, against a year earlier

4.97 0.02 +0.40%
Market cap
$39.9M
P/E
0.0×
Fwd P/E
65.1×
Dividend yield
0.00%
F-score
6/9
Altman Z
−0.23
Beneish M
−3.17
Dividend safety
20/100
Aug '26 May '26 Feb '26 Nov '25 Older periods
Piotroski F-Score
6 6 6 6

+8 more TTM periods

ROE
12.46% 14.80% 16.12% 15.27%
ROA
(3.10%) (3.94%) (4.26%) (3.84%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(10.58%) (15.37%) (18.79%) (18.69%)
Average Days of Receivables
80.14 81.03 79.53 79.16
Free Cash Flow per Share
0.58 0.76 0.63 0.66
Free Cash Flow
4.65 6.11 5.06 5.36
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026